Literature DB >> 9773394

Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data.

R C Gagnon1, J J Peterson.   

Abstract

The area under the curve (AUC) of the concentration-time curve for a drug or metabolite, and the variation associated with the AUC, are primary results of most pharmacokinetic (PK) studies. In nonclinical PK studies, it is often the case that experimental units contribute data for only a single time point. In such cases, it is straightforward to apply noncompartmental methods to determine an estimate of the AUC. In this report, we investigate noncompartmental estimation of the AUC using the long-trapezoidal rule during the elimination phase of the concentration-time profile, and we account for the underlying distribution of data at each sampling time. For data that follow a normal distribution, the log-trapezoidal rule is applied to arithmetic means at each time point of the elimination phase of the concentration-time profile. For data that follow a lognormal distribution, as is common with PK data, the log-trapezoidal rule is applied to geometric means at each time point during elimination. Since the log-trapezoidal rule incorporates nonlinear combinations of mean concentrations at each sampling time, obtaining an estimate of the corresponding variation about the AUC is not straightforward. Estimation of this variance is further complicated by the occurrence of lognormal data. First-order approximations to the variance of AUC estimates are derived under the assumptions of normality, and lognormality, of concentrations at each sampling time. AUC estimates and variance approximations are utilized to form confidence intervals. Accuracies of confidence intervals are tested using simulation studies.

Mesh:

Year:  1998        PMID: 9773394     DOI: 10.1023/a:1023228925137

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  9 in total

1.  Performance of Bailer's method for AUC confidence intervals from sparse non-normally distributed drug concentrations in toxicokinetic studies.

Authors:  S M Pai; J R Nedelman; G Hajian; E Gibiansky; V K Batra
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

2.  Randomization tests for assessing the equality of area under curves for studies using destructive sampling.

Authors:  A J Bailer; S J Ruberg
Journal:  J Appl Toxicol       Date:  1996 Sep-Oct       Impact factor: 3.446

3.  The variance of a better AUC estimator for sparse, destructive sampling in toxicokinetics.

Authors:  J R Nedelman; E Gibiansky
Journal:  J Pharm Sci       Date:  1996-08       Impact factor: 3.534

4.  A note on testing areas under the curve when using destructive measurement techniques.

Authors:  H Heinzl
Journal:  J Pharmacokinet Biopharm       Date:  1996-12

5.  Testing for the equality of area under the curves when using destructive measurement techniques.

Authors:  A J Bailer
Journal:  J Pharmacokinet Biopharm       Date:  1988-06

6.  Estimation of variance for AUC in animal studies.

Authors:  J Yuan
Journal:  J Pharm Sci       Date:  1993-07       Impact factor: 3.534

7.  Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

8.  A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation.

Authors:  K C Yeh; K C Kwan
Journal:  J Pharmacokinet Biopharm       Date:  1978-02

9.  Applying Bailer's method for AUC confidence intervals to sparse sampling.

Authors:  J R Nedelman; E Gibiansky; D T Lau
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

  9 in total
  28 in total

1.  Variability of the model-independent AUC: the one sample per individual case.

Authors:  W Jawień
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

2.  Establishing bioequivalence in serial sacrifice designs.

Authors:  Martin J Wolfsegger
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-10-12       Impact factor: 2.745

3.  Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs.

Authors:  Martin J Wolfsegger; Thomas Jaki
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-10-22       Impact factor: 2.745

4.  Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus.

Authors:  F Krenzien; M Quante; T Heinbokel; M Seyda; K Minami; H Uehara; H R C Biefer; J M Schuitenmaker; S Gabardi; K Splith; M Schmelzle; A K Petrides; H Azuma; J Pratschke; X C Li; A ElKhal; S G Tullius
Journal:  Am J Transplant       Date:  2016-11-21       Impact factor: 8.086

5.  Comparison of tenofovir plasma and tissue exposure using a population pharmacokinetic model and bootstrap: a simulation study from observed data.

Authors:  Jon W Collins; J Heyward Hull; Julie B Dumond
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-11-08       Impact factor: 2.745

6.  Deoxyhypusine synthase promotes differentiation and proliferation of T helper type 1 (Th1) cells in autoimmune diabetes.

Authors:  Stephanie C Colvin; Bernhard Maier; David L Morris; Sarah A Tersey; Raghavendra G Mirmira
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

7.  A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity.

Authors:  Hong-Bo Pang; Gary B Braun; Zhi-Gang She; Venkata R Kotamraju; Kazuki N Sugahara; Tambet Teesalu; Erkki Ruoslahti
Journal:  J Control Release       Date:  2013-12-15       Impact factor: 9.776

8.  The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions.

Authors:  Igor Odintsov; Allan J W Lui; Whitney J Sisso; Eric Gladstone; Zebing Liu; Lukas Delasos; Renate I Kurth; Exequiel M Sisso; Morana Vojnic; Inna Khodos; Marissa S Mattar; Elisa de Stanchina; Shawn M Leland; Marc Ladanyi; Romel Somwar
Journal:  Clin Cancer Res       Date:  2021-04-06       Impact factor: 12.531

9.  Inactivation of posterior but not anterior dorsomedial caudate-putamen impedes learning with self-administered nicotine stimulus in male rats.

Authors:  Christopher L Robison; Theodore Kazan; Rikki L A Miller; Nicole Cova; Sergios Charntikov
Journal:  Behav Brain Res       Date:  2021-07-03       Impact factor: 3.352

10.  A new framework for prediction and variable selection for uncommon events in a large prospective cohort study.

Authors:  Hye-Seung Lee; Jeffrey P Krischer
Journal:  Model Assist Stat Appl       Date:  2017-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.